Poltreg S.A. (WSE:PTG)

Poland flag Poland · Delayed Price · Currency is PLN
18.70
-0.50 (-2.60%)
Jun 16, 2026, 4:14 PM CET
Market Cap113.60M -30.4%
Revenue (ttm)n/a
Net Income-27.31M
EPS-5.86
Shares Out 5.92M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,741
Open19.20
Previous Close19.20
Day's Range18.70 - 19.35
52-Week Range16.00 - 36.00
Beta0.91
AnalystsStrong Buy
Price Target67.30 (+259.89%)
Earnings DateSep 9, 2026

About Poltreg

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdańsk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 37
Stock Exchange Warsaw Stock Exchange
Ticker Symbol PTG
Full Company Profile

Financial Performance

Financial Statements

News

Poltreg Quarterly report: Q1 2026

Poltreg has published its Q1 2026 quarterly earnings report on May 11, 2026.

5 weeks ago - Filings

Poltreg Annual report: Q4 2025

Poltreg has published its Q4 2025 annual report on April 30, 2026.

6 weeks ago - Filings

Poltreg Quarterly report: Q3 2025

Poltreg has published its Q3 2025 quarterly earnings report on November 19, 2025.

7 months ago - Filings

Poltreg Quarterly report: Q2 2025

Poltreg has published its Q2 2025 quarterly earnings report on September 10, 2025.

9 months ago - Filings